244 related articles for article (PubMed ID: 15108761)
1. The cost of chronic obstructive pulmonary disease and its effects on managed care.
Mapel D; Chen JC; George D; Halbert RJ
Manag Care Interface; 2004 Apr; 17(4):61-6. PubMed ID: 15108761
[TBL] [Abstract][Full Text] [Related]
2. Smoking-related diseases: the importance of COPD.
Zaher C; Halbert R; Dubois R; George D; Nonikov D
Int J Tuberc Lung Dis; 2004 Dec; 8(12):1423-8. PubMed ID: 15636487
[TBL] [Abstract][Full Text] [Related]
3. Cost impact of COPD in Japan: opportunities and challenges?
Nishimura S; Zaher C
Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and global impact of chronic obstructive pulmonary disease.
Mannino DM
Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437
[TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease (COPD) is a major personal and public health burden in Australia.
Frith PA; Cafarella PA; Duffy JM
Aust N Z J Public Health; 2008 Apr; 32(2):139-41. PubMed ID: 18412684
[TBL] [Abstract][Full Text] [Related]
6. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
7. Chronic obstructive pulmonary disease: diagnosis and management.
Downs CA; Appel SJ
J Am Acad Nurse Pract; 2007 Mar; 19(3):126-32. PubMed ID: 17341279
[TBL] [Abstract][Full Text] [Related]
8. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and managed care: a convincing case for action.
Gorshow S
Manag Care Interface; 2007 Mar; 20(3):26-7. PubMed ID: 17458478
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacoeconomics of vaccinations in chronic obstructive pulmonary disease].
Słominski JM; Kubiak A
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():83-5. PubMed ID: 15524025
[TBL] [Abstract][Full Text] [Related]
12. Economics of COPD: literature review and experiences from field work.
Nielsen R; Klemmetsby M; Gulsvik A
Clin Respir J; 2008 Oct; 2 Suppl 1():104-10. PubMed ID: 20298358
[TBL] [Abstract][Full Text] [Related]
13. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
15. The burden of obstructive lung disease in Medicaid and managed care populations.
Shaya FT
Manag Care; 2005 Jul; 14(7 Suppl Obstructie Lung):20-3; discussion 24-6. PubMed ID: 18564561
[No Abstract] [Full Text] [Related]
16. [Costs of chronic obstructive pulmonary disease treatment].
Targowski T; Jahnz-Rózyk K
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():86-7. PubMed ID: 15524026
[TBL] [Abstract][Full Text] [Related]
17. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004
[TBL] [Abstract][Full Text] [Related]
18. Chronic obstructive pulmonary disease: the impact occurs earlier than we think.
Tinkelman D; Corsello P
Am J Manag Care; 2003 Nov; 9(11):767-71; quiz 772-3. PubMed ID: 14626474
[TBL] [Abstract][Full Text] [Related]
19. Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care.
Joo MJ; Au DH; Lee TA
Transl Res; 2009 Sep; 154(3):103-10. PubMed ID: 19665686
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of smoking-related disease in Thailand: a prevalence-based analysis.
Leartsakulpanitch J; Nganthavee W; Salole E
J Med Assoc Thai; 2007 Sep; 90(9):1925-9. PubMed ID: 17957939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
